Capecitabine monotherapy in advanced breast cancer resistant to anthracycline and taxane: A meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching AU Zhansheng Jiang
Results: 23
1
2
Glutamate promotes triple-negative breast cancer development through IRE1α/XBP1-mediated macrophage polarization: mechanism insights and therapy.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02790-y
- By:
- Publication type:
- Article
3
Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
- Published in:
- Apoptosis, 2024, v. 29, n. 5/6, p. 681, doi. 10.1007/s10495-023-01932-3
- By:
- Publication type:
- Article
4
Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway.
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 676
- By:
- Publication type:
- Article
5
Sophoridine suppresses cell growth in human medulloblastoma through FoxM1, NF‑κB and AP‑1.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7941, doi. 10.3892/ol.2017.7224
- By:
- Publication type:
- Article
6
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2523, doi. 10.1007/s00262-020-02641-5
- By:
- Publication type:
- Article
7
Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10637-4
- By:
- Publication type:
- Article
8
MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 2, p. 856, doi. 10.1159/000487180
- By:
- Publication type:
- Article
9
MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 2, p. 856, doi. 10.1159/000487180
- By:
- Publication type:
- Article
10
Advances and optimization in the treatment schedule of HER2-positive breast cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2020, v. 27, n. 5, p. 469, doi. 10.3872/j.issn.1007-385X.2020.05.001
- By:
- Publication type:
- Article
11
A case of tonsillar metastasis from breast cancer and literature review.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
12
Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway.
- Published in:
- Tohoku Journal of Experimental Medicine, 2022, v. 257, n. 4, p. 283, doi. 10.1620/tjem.2022.J030
- By:
- Publication type:
- Article
13
Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial.
- Published in:
- Integrative Cancer Therapies, 2018, v. 17, n. 2, p. 444, doi. 10.1177/1534735417725578
- By:
- Publication type:
- Article
14
Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-1107-4
- By:
- Publication type:
- Article
15
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 23, p. 3420, doi. 10.1111/1759-7714.14693
- By:
- Publication type:
- Article
16
Serum IL‐35 levels is a new candidate biomarker of cancer‐related cachexia in stage IV non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 5, p. 716, doi. 10.1111/1759-7714.14307
- By:
- Publication type:
- Article
17
Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 17, p. 2369, doi. 10.1111/1759-7714.14079
- By:
- Publication type:
- Article
18
Expression of OPN3 in lung adenocarcinoma promotes epithelial‐mesenchymal transition and tumor metastasis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 286, doi. 10.1111/1759-7714.13254
- By:
- Publication type:
- Article
19
Clinicopathological characteristics, diagnosis, and prognosis of pregnancy‐associated breast cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 5, p. 1060, doi. 10.1111/1759-7714.13045
- By:
- Publication type:
- Article
20
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non‐T790M mutations after progression on first‐line EGFR‐tyrosine kinase inhibitors.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 9, p. 1151, doi. 10.1111/1759-7714.12814
- By:
- Publication type:
- Article
21
UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 3, p. 699, doi. 10.1007/s10549-020-05899-6
- By:
- Publication type:
- Article
22
Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.800951
- By:
- Publication type:
- Article
23
Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2017, v. 20, n. 2, p. 138, doi. 10.3779/j.issn.1009-3419.2017.02.09
- By:
- Publication type:
- Article